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* Owing to the upp mutation, this strain and its derivatives require uridine (1 m) rather than uracil. 
RESULTS A N D D I S C U S S I O N 2'
; 3'-Cyclic phosphodiesterase (Anraku, 1964 a, b) catalyses the following two-step reaction : 2' : 3'-cyclic UMP --f 3'-UMP -+ uridine +phosphate. Other nucleotides, e.g. 2' : 3'-cyclic AMP, are also hydrolysed (Anraku, 1964 a) . Following mutagenesis of strain AB1157-1 with nitrosoguanidine, cpdB mutants were selected as resistant to a mixture of 5-fluorouracil(l pg ml-l) and 3'-AMP (1 r n~) (see Beacham et al., 1973 , for further details).
Two mutant clones, GU13 and GU26, were eventually obtained which were deficient in 2' : 3'-cyclic phosphodiesterase and 3'-nucleotidase activity as shown in Table 2 . The 3'-nucleotidase deficiency is particularly incomplete presumably due to other periplasmic enzymes capable of hydrolysing 3'-nucleotides (Dvorak et ill., 1967) . Anraku (19643) has provided evidence that the hydrolysis of cyclic-and 3'-nucleotides by cyclic phosphodiesterase occurs at different sites on the enzyme. The two mutants reported here show loss of both activities indicating that an active site is not specifically altered, but rather a complete loss of function of the protein. However, it might nevertheless be possible, on the basis of two active sites, to isolate mutants affected in either cyclic-or 3'-nucleotide hydrolysis.
Though resistant to 5-fluorouracil plus 3'-AMP, this phenotype was not clear enough to be used for mapping studies, and an alternative phenotype was sought. A uracil, or uridine, requirement was conferred on GU13 by the introduction of a pyrE mutation as outlined in Table 1 . Whereas cpdB+pyrE strains will utilize cyclic UMP or 3'-UMP as a uracil source, cpdB pyrE strains will not. This provides a very clear phenotypic distinction between cpdB+ and cpdB strains, but only in apyr background. Genetic mapping Preliminary mapping was performed using conjugation. Selection for Arg+, Leu+ and Cpd+ recombinants using HfrRa-2 and HfrC indicated that cpdB was linked to argE and leu to the extent of 20 to 50%. However, cpdB did not enter with HfrH when Leu+ was selected. This placed cpdB between the origins of HfrRa-2 and HfrH (Fig. 1 ) . Subsequent studies (Table 3 ) have shown the transductional relationships depicted in Fig. 2 . The threefactor data from cross 1 ( Table 3 ) is inconsistent with ampA or cpdB as the middle marker, placing cpdB to the right of purA, in the order ampA-purA-cpdB. Crosses 2 and 3 show that cpdB is closely linked to cycA and concur that it lies to the right of cycA. The linkage values of cpdB and cycA to purA, when the latter is selected (cross 21, agree with the gene 3-2 order deduced from the three-factor data. The higher value for purA-cpdB obtained in cross 3 is less reliable to compare with thepurA-cycA distance since it is obtained in a different cross, selecting a different marker, and lower numbers were scored.
Two different values for the distance between purA and cycA exist in the literature ( Fig. 2 ; Russell, 1972; Isono & Kitakawa, 1978) ; our data are consistently in agreement with the higher value. Cross 4 shows the expected low degree of cotransduction to valS.
By converting the cotransduction frequencies to minutes using the Wu formula (Wu, 1966) , the total genetic distance between dmpA and Vdls based on additivity of cotransduction frequency is 2.4 min; this is about 0.3 min greater than indicated in the current edition of the E. coN genetic map (Bachmann et al., 1976) .
In summary, the cpdB gene is placed about 0.11 min, or approximately 4-5 kilobases, to the right of the cycA locus.
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